Leidos Holdings Aktie
| 129,01USD | -2,49USD | -1,89% |
WKN DE: A1W5CT / ISIN: US5253271028
Personal
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 39 000 | 43 000 | 45 000 | 47 000 | 48 000 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,32 | 0,32 | 0,32 | 0,33 | 0,35 |
Bilanz (in Mio. USD) - Aktiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 3 228 | 3 504 | 3 511 | 3 904 | 4 335 |
| Summe Anlagevermögen | 9 283 | 9 757 | 9 560 | 8 791 | 8 769 |
| Summe Aktiva | 12 511 | 13 261 | 13 071 | 12 695 | 13 104 |
Bilanz (in Mio. USD) - Passiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 8 640 | 8 917 | 8 718 | 8 437 | 8 644 |
| Summe Eigenkapital | 3 871 | 4 344 | 4 353 | 4 258 | 4 460 |
| Summe Passiva | 12 511 | 13 261 | 13 071 | 12 695 | 13 104 |
Adresse
| 1750 Presidents Street, 20190 Reston | |
| Telefon | +1 (571) 526-6000 |
| Internet | http://www.leidos.com |
Management
|
Al Potter
MD-National Security & Defence Business-UK |
|
Amy Smith
Senior Vice President-Government Affairs |
|
Brian Z Liss
Secretary, Senior VP & Deputy General counsel |
|
Carly Kimball
Chief Performance Officer |
|
Christopher R. Cage
Chief Financial Officer & Executive Vice President |
|
Daniel A. Atkinson
Chief Accounting Officer, Senior VP & Controller |
|
Daniel J. Antal
General Counsel |
|
David G. Fubini
Independent Director |
|
Debbie Opiekun
Chief Business Development Officer |
|
Donald Kosiak
Chief Medical Officer & Senior Vice President |
|
Essye B Miller
Board Advisor |
|
Gary Stephen May
Independent Director |
|
Gerry A. Fasano
Chief Growth Officer |
|
Gregory R. Dahlberg
Independent Director |
|
Harry M. Jansen Kraemer
Independent Director |
|
James F. Carlini
Chief Technology Officer |
|
Leslie Fautsch
Chief Human Resources Officer |
|
Liz Porter
President-Health & Civil Sector |
|
Michele M. Brown
Senior VP, Chief Ethics & Compliance Officer |
|
Mike Eddings
Vice President-Director-Operations-Leidos Health |
|
Nancy A. Norton
Independent Director |
|
Noel Brown Geer
Independent Director |
|
Patrick M. Shanahan
Independent Director |
|
Paul O. Engola
Executive Vice President-National Security Space |
|
Robert C. Kovarik
Independent Director |
|
Robert S. Shapard
Independent Non-Executive Chairman |
|
Ron Keesing
Chief Artificial Intelligence Officer |
|
Roy Stevens
President-National Security Sector |
|
Steve Hull
President-Digital Modernization Sector |
|
Stuart M. Davis
Investor Relations Contact |
|
Surya Narayan Mohapatra
Independent Director |
|
Susan M. Stalnecker
Independent Director |
|
Thomas A. Bell
Chief Executive Officer & Director |
|
Thomas J. Downey
EVP, Chief Communications & Marketing Officer |
|
Thomas Sanglier
Chief Audit Executive & Senior Vice President |
|
Tina W. Jonas
Independent Director |
|
Vicki Schmanske
President-Commercial & International Sector |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.